Metlaril en es it fr

Metlaril Brand names, Metlaril Analogs

Metlaril Brand Names Mixture

  • No information avaliable

Metlaril Chemical_Formula


Metlaril RX_link

Metlaril fda sheet

Metlaril msds (material safety sheet)

Metlaril MSDS

Metlaril Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Metlaril Molecular Weight

370.577 g/mol

Metlaril Melting Point

73 oC

Metlaril H2O Solubility

0.0336 mg/L

Metlaril State


Metlaril LogP


Metlaril Dosage Forms

Suspension; Tablet

Metlaril Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Metlaril Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Metlaril Absorption


Metlaril side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Metlaril Patient Information

Metlaril Organisms Affected

Humans and other mammals